At1g59030 Antibody
Description
Overview of At1g59030 Antibody
The At1g59030 antibody is a monoclonal or polyclonal reagent generated to detect and quantify the protein product of the At1g59030 gene in Arabidopsis thaliana. This gene is part of the plant's genome, though its precise biological function remains under investigation. The antibody is typically used in techniques such as Western blotting (WB), immunohistochemistry (IHC), and enzyme-linked immunosorbent assays (ELISA) .
Research Applications
The At1g59030 antibody enables:
-
Protein Localization: Tracking subcellular distribution via IHC.
-
Expression Profiling: Quantifying protein levels under different growth conditions or stressors.
-
Interaction Studies: Identifying binding partners through co-immunoprecipitation (Co-IP).
Notably, studies on analogous Arabidopsis antibodies (e.g., GH3.1, GSTF10) reveal applications in plant-pathogen interactions and abiotic stress responses, suggesting potential utility for At1g59030 investigations .
Validation and Specificity Considerations
Antibody specificity is critical for accurate results. While commercial providers like Cusabio validate antibodies for target binding, independent verification is recommended. For example:
-
Western Blot: A single band at the expected molecular weight (~50–70 kDa, depending on post-translational modifications) confirms specificity .
-
Knockout Controls: Testing in Arabidopsis lines lacking At1g59030 can rule out cross-reactivity, a method validated in studies critiquing non-specific antibodies .
Limitations and Future Directions
-
Limited Functional Data: The biological role of At1g59030 remains uncharacterized, necessitating functional genomics approaches (e.g., CRISPR knockout studies).
-
Antibody Cross-Reactivity: As shown in angiotensin receptor antibody studies , commercial reagents may exhibit off-target binding without rigorous validation.
Comparative Analysis with Related Antibodies
The table below contrasts At1g59030 with other Arabidopsis-specific antibodies:
| Antibody | Target Gene | Function | Applications |
|---|---|---|---|
| At1g59030 Antibody | At1g59030 | Unknown | WB, IHC, ELISA |
| GH3.1 Antibody | GH3.1 | Auxin homeostasis | Stress response studies |
| GSTF10 Antibody | GSTF10 | Detoxification enzymes | Oxidative stress assays |
Data synthesized from Cusabio and Arabidopsis functional studies .
Product Specs
Components: 50% Glycerol, 0.01M PBS, pH 7.4
Target Background
KEGG: ath:AT1G58725
Q&A
FAQs for Researchers on AT1R Antibodies in Academic Research
Advanced Research Questions
-
How can contradictory data from different AT1R antibodies be resolved in mechanistic studies?
-
Methodological Answer:
-
Compare results across ≥3 independent antibodies with distinct epitopes. For example, antibodies targeting extracellular vs. intracellular AT1R domains may yield divergent results .
-
Integrate pharmacological validation (e.g., nanobody antagonists) to isolate antibody-specific effects from off-target interactions .
-
-
-
What strategies exist for studying AT1R antibody effects in disease models with preexisting inflammation?
-
How can researchers engineer AT1R antibodies for tissue- or cell type-specific targeting?
Data Table: Key Findings from AT1R Antibody Studies
Methodological Recommendations
-
For mechanistic studies, combine AT1R antibodies with CRISPR-mediated receptor knockdown to isolate antibody-specific effects .
-
In drug discovery, leverage tetravalent bispecific formats (e.g., PD-L1×4-1BB) to enhance tumor microenvironment specificity while reducing systemic toxicity .
-
Address contradictory data by reporting antibody lot numbers, dilution factors, and validation workflows (e.g., "Antibody X, Lot Y: Validated in HEK293-AT1R vs. parental cells at 1:1,000 dilution") .
